MoonLake Immunotherapeutics
MoonLake Immunotherapeutics（MLTX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
mltx · 股价预测 · 18 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 18 位华尔街分析师
Buy
18 位分析师
共识
评级分布
12 个月目标价
High
$45.00
Consensus
$28.50
+59.5% upside
Low
$10.00
Median: $29.5 · Last Close: $17.87
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$28.50
59.5% upside
High Target
$45
151.8%
Low Target
$10
-44.0%
Current Price
$17.87
as of today
Based on analyst price targets, the MLTX stock price prediction for the next 12 months ranges from $10 to $45. The consensus MLTX price forecast of $28.50 implies 59.5% upside from the current price of $17.87.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $17.87 | ↓ 0.00% |
1-day model range: $17.75–$17.99. Peak: $17.99 (-0.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MLTX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-12 | Needham | Maintains | Buy→Buy |
| 2026-05-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-30 | BTIG | Maintains | Buy→Buy |
| 2026-03-23 | Wolfe Research | Upgrade ↑ | Underperform→Outperform |
| 2026-03-19 | Rothschild & Co | Upgrade ↑ | Neutral→Buy |
| 2026-03-11 | Clear Street | Maintains | Buy→Buy |
| 2026-03-02 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2026-03-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-26 | Needham | Maintains | Buy→Buy |
| 2026-02-24 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on MoonLake Immunotherapeutics (MLTX) stock. Of the recent 102 rating actions, 6 were upgrades and 7 were downgrades. 18 analysts currently cover MLTX.
分析师推荐趋势
MLTX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$23M
EPS This Year
$-3.83
EPS Next Year
$-3.64
↓ 5.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast MLTX EPS of $-3.83 for the current fiscal year, based on estimates from 7 analysts. The MLTX revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
MLTX 股价预测由两类独立数据源支撑：来自 18 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。MLTX 的共识目标价为 $28.50（+59.5% 上行空间），分析师共识为 Buy。
MLTX 的短期预测（明日）为 $17.87（-0.00%）。
MoonLake Immunotherapeutics 在 NASDAQ 上市，代码 MLTX。MLTX 在 2027 年的整体展望偏积极，在覆盖分析师中约 78% 对应 Buy 共识。
常见问题
MLTX 预测 · 8 个问题根据 18 位华尔街分析师，MLTX 的 12 个月平均目标价为 $28.50，最高 $45.00、最低 $10.00。若有图表，中位目标价可在上方查看。相对当前价 $17.87，隐含约 +59.5% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.